Anticoagulants Market Size to hit $43.42 million by 2025, at CAGR of 7.5% With Top Companies Daiichi Sankyo Company, Limited, GlaxoSmithKline plc.

Increase in prevalence of DVT, PE, and cardiac disease across the world plays a major role in the growth of the anticoagulant drugs market. Furthermore, increase in adoption of NOACs is expected to boost the demand for anticoagulants in the coming years.

The global anticoagulants market generated $26.11 billion in 2018, and is projected to generate $43.42 billion by 2025, registering a CAGR of 7.5% from 2018 to 2025.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/1673?reqfor=covid

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1673

In addition, increasing number of geriatric population and growing incidence of obese population is expected to further increase the demand for anticoagulants throughout the forecast period. On the other side, very high cost of NOACs is expected to negatively affect the growth of the anticoagulants market.

Based on the drug class, the NOACs segment held more than half of the total share of the global anticoagulants market in 2018, and is estimated to maintain its leadership position in terms of revenue during the forecast period. Moreover, this segment is expected to witness the highest CAGR of 8.0% from 2018 to 2025. The report also analyzes segments including heparins & LMWH, vitamin K antagonists, and others.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1673

Based on route of administration, the oral anticoagulants segment accounted for the highest share in 2018, holding nearly two-thirds of the total share of the global anticoagulants market. Moreover, this segment is estimated to register the highest CAGR of 7.7% from 2018 to 2025. The report also discusses the injectable anticoagulants segment.

Based on application, the atrial fibrillation & heart attack segment held the largest share in 2018, accounting for more than two-fifths of the total share of the global market, and will maintain its dominant position by 2025. However, the deep vein thrombosis (DVT) segment is expected to maintain the largest growth rate with a CAGR of 8.4% during the forecast period.

Geographically, North America contributed to nearly half of the total share of the global anticoagulants market in 2018, and is expected to maintain its lead position on the basis of revenue during the forecast period. However, Asia-Pacific is estimated to witness the highest CAGR of 9.2% from 2019 to 2026.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/anticoagulant-drugs-market

The Major Key Players Are:

• Aspen Holdings
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Daiichi Sankyo Company, Limited
• GlaxoSmithKline plc.
• Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
• Pfizer, Inc.
• Portola Pharmaceuticals, Inc.
• Sanofi S.A.

Similar Reports:

Infant Incubator Market : https://www.pharmiweb.com/press-release/2020-09-15/infant-incubator-market-value-to-hit-401-million-by-2023-at-cagr-of-59-amr

Indian Laparoscopy Devices Market : https://www.pharmiweb.com/press-release/2020-09-16/laparoscopy-devices-market-in-indian-top-companies-analysis-to-growing-at-cagr-of-73-by-2023

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.